The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (11 analysts) rates it strong buy, with a mean price target of $35. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
BKV Corporation
BKV · the NYSE · USD · Market cap $2.3B · 452 employees
BKV Corporation produces and sells natural gas in the Barnett Shale in the Fort Worth Basin of Texas and in the Marcellus Shale in the Appalachian Basin of Northeast Pennsylvania.
PASS · Titan Ethical · score 70.0Price as of 28 Oct 2026Daily close, not a live quote
Screened 2026-10-28 · the tape above runs as of 10:09 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price21.17 USD at the 28 Oct 2026 close
- Ethical screenPasses, score 70.0 out of 100
- OptionsOpen interest leans heavily to calls (put/call 0.23)
- Last reviewed28 Oct 2026 (1 days ago)
A summary of the dated readings below, not a live quote and not advice.
What this means: price 21.17 against the desk's fair-value range, base estimate 26.56, over the last year.
- Trend Distribution
- Insiders insiders sold, $103,549, latest filing 2026-10-23
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.23, read 2026-10-28
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
BKV Corporation holds its Distribution at $21.17. Elevated stress, defensive posture warranted, held for 1 days.
| Phase | Distribution · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 1 days |
| Price at the screen | $21.17 |
| Valuation | 7.42 trailing · 9.66 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.12 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 15.55% | Below 33% | Interest-bearing debt is just 15.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 9.95% | Below 49% | Money owed to the company is 10.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.18% | Below 5% | Only 0.2% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
BKV clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 16%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when BKV's ethical verdict changes
Today BKV passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value range in USD, drawn from the 2026-10-28 screen. The gold marker is the market price at the same screen. A 25.4% margin of safety to the base estimate.
Third-party analyst targets: 11 covering, consensus Strong Buy. The average target sits +65% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-28 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsGas Producer Looks Cheap but Traps Await
Picture a drill rig in Texas or Pennsylvania humming away while gas prices swing like a pendulum. BKV pulls natural gas from the Barnett and Marcellus shales and moves it through its own gathering lines and power assets. Revenue jumped 39 percent and margins sit at 30 percent with a 17 percent return on equity, yet the forward multiple of 11.9 times already prices in peak conditions.
The business clears our ethical screen without issue and analysts see further upside. Still we pass. In a cyclical energy patch a low multiple often signals earnings that are about to roll over rather than a bargain waiting to be claimed.
Commodity prices can drop fast and stay low, cutting cash flow and leaving balance sheets exposed. The slim margin of safety offers little cushion once volumes or prices turn. Analysis, not advice.
| Forward P/E | 9.7xcheap for a company growing this fast |
| Trailing P/E | 7.4xvery cheap relative to earnings |
| EPS, trailing | 2.79 |
| EPS, forward | 2.14 |
| Revenue growth | +18.8%steady growth |
| Profit margin | 25.5%healthy profit margins |
| Return on equity | 14.1%a solid return on shareholder capital |
| FCF yield | -30.79% |
| Debt to equity | 0.53moderate, manageable leverage |
| Current ratio | 1.15adequate liquidity, worth monitoring |
| Beta | 1.12moves a little more than the market |
| Short interest, float | 0.25% |
| 52-week range | 20.17 - 32.81 |
| Market cap | $2.3B |
| Employees | 452 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBKV trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 7.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (11 analysts) rates it strong buy, with a mean price target of $35. Insiders have been net sellers over the past quarter. Since the last review it its composite score rose.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 8.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (11 analysts) rates it strong buy, with a mean price target of $35. Insiders have been net sellers over the past quarter.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (11 analysts) rates it strong buy, with a mean price target of $35. Insiders have been net sellers over the past quarter.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 12.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (11 analysts) rates it strong buy, with a mean price target of $35. Insiders have been net sellers over the past quarter.
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (11 analysts) rates it strong buy, with a mean price target of $35.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (11 analysts) rates it strong buy, with a mean price target of $35.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 15%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (11 analysts) rates it strong buy, with a mean price target of $35.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 3 small-cap stocks that fall short Yahoo Finance · 6d ago
- 3 Cash-Burning Stocks We Steer Clear Of Yahoo Finance · 9d ago
- BKV Corporation Announces Timing of Third Quarter 2026 Earnings Release and Conference Call Details Yahoo Finance · 14d ago
- 1 Energy Stock with Exciting Potential and 2 We Turn Down Yahoo Finance · 16d ago
- Why BKV (BKV) Is Up 12.4% After Hyperscaler-Backed 1,200 MW Texas Power Deal News Yahoo Finance · 19d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-23 | Hinojosa Javier | SVP of Power | S - Sale | 4,952 | $103,549 |
| 2026-09-25 | Hinojosa Javier | SVP of Power | S - Sale | 7,428 | $168,321 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $28.34 | -7.9% | · | $921 | -7.9% |
| 2 months | $28.18 | -7.4% | · | $926 | -7.4% |
| 3 months | $28.05 | -7.0% | · | $930 | -7.0% |
| 6 months | $28.82 | -9.5% | · | $905 | -9.5% |
| 1 year | $22.61 | +15.4% | · | $1,154 | +15.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BKV does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.